Condition

Light Chain (AL) Amyloidosis clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• How well minimal residual disease is cleared in AL amyloidosis after first-line Dara-BorCyD

  This study tests whether achieving very good partial or complete marrow responses with Dara-BorCyD and planned stem cell transplant helps AL amyloidosis patients, by looking at minimal residual disease after treatment.

  Recruiting Peking University First Hospital · Beijing, Beijing Municipality · NCT07215494

• Using daratumumab to treat patients with light chain amyloidosis

  This study is testing how well daratumumab works for treating light chain amyloidosis in different groups of patients to find the best way to help them.

  Recruiting Nanjing University School of Medicine · Nanjing, Jiangsu · NCT06376214

Related topics

Quick answers

How many Light Chain (AL) Amyloidosis clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →